Evidence map›Paper›PMID 30154405›Full record

ArticleNature communications2018

Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment.

Hannah L Mackay, David Moore, Callum Hall, Nicolai J Birkbak, Mariam Jamal-Hanjani, Saadia A Karim, Vinaya M Phatak, Lucia Piñon, Jennifer P Morton, Charles Swanton and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Hannah L MackayMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK.
David MooreMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK.
Callum HallCancer Research UK Manchester Institute, The University of Manchester | Alderley Park, SK10 4TG, Manchester, UK.
Nicolai J BirkbakTranslational Cancer Therapeutics Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Mariam Jamal-HanjaniDepartment of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.
Saadia A KarimInstitute of Cancer Sciences, University of Glasgow, Switchback Road, Glasgow, G61 1BD, UK.
Vinaya M PhatakMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK.
Lucia PiñonMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK.
Jennifer P MortonInstitute of Cancer Sciences, University of Glasgow, Switchback Road, Glasgow, G61 1BD, UK.
Charles SwantonTranslational Cancer Therapeutics Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
John Le QuesneMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK. jlq2@le.ac.uk.
Patricia A J MullerMRC Toxicology Unit, Lancaster Road, LE1 9HN, Leicester, UK. patricia.muller@manchester.ac.uk.

Funding

Cancer Research UK 17786Cancer Research UK 21999
6 · The paper itself

Abstract

The original version of this article incorrectly omitted an affiliation of Patricia A. J. Muller: 'Cancer Research UK Manchester Institute, The University of Manchester | Alderley Park, Manchester, SK10 4TG, UK'. This has been corrected in both the PDF and HTML versions of the Article.

Identifiers

PMID30154405
PMCPMC6113285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.